Key Metrics of Abbott Laboratories
Revenue$40.1B▼ 8.1% YoYFY 2023
Operating income$6.5B▼ 22.5% YoY
Net profit$5.7B▼ 17.5% YoY
Shareholders' equity$38.6B
Market cap$177BABT · $102.51
Competitors10identified
About Abbott Laboratories
Sectors
Company details
- Website
- abbott.com
- Listed
- NYSE: ABT
Operational Areas of Abbott Laboratories
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameAbbott Laboratories
TickerABT
ExchangeNYSE
CountryUnited States
SEC CIK0000001800
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://abbott.com
US market & SEC filings
ABT · NYSE · SEC CIK 0000001800
Last price · 24 Oct 2026
$102.51
+1.99%
Market cap$177B
P/E31.4On FY 2023 diluted EPS
Volume10,661,567
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States
ABT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeNorth Chicago
GSTIN—
Email—
Websitehttps://abbott.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Abbott Laboratories
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
S
Sai Life Sciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
B
Brooks Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
M
Morepen Laboratories LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
N
Nectar Lifesciences LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
T
Themis Medicare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
S
Sakar Healthcare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
I
IOL Chemicals and Pharmaceuticals Ltd. (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
Poly Medicure (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
medical technology industry
Filings
No filings on record yet.